Most recent update: Wednesday, July 4, 2018 - 15:30

Bariatric News - Cookies & privacy policy

You are here

%2 News

02/05/18 - Industry
Product approval
Apollo Endosurgery has announced that the Saudi Food and Drug Authority (SFDA) has approved the Orbera365 Managed Weight Loss System and has issued a Medical Device Marketing Authorization (MDMA) for...
03/05/18 - Industry
Product approval
ReShape Lifesciences has announced approval of the company's ReShape Balloon by the Kingdom of Saudi Arabia Saudi Food and Drug Authority. Congruent with this approval, the company received an...
23/02/18 - Industry
Product approval
Apollo Endosurgery has announced that the South Korean Ministry of Food and Drug Safety’s (MFDS) has approved of its Orbera Intragastric Balloon System to assist adult patients who are overweight...
07/02/18 - Industry
ENLIGHTEN Elipse Balloon study
Allurion Technologies has started the ENLIGHTEN clinical trial for the Elipse Balloon – the world’s first and only procedureless gastric balloon for weight loss. ENLIGHTEN is a randomised, sham-...
07/12/17 - Industry
Product approval
Crospon, an endoscopic diagnostics company, has received FDA clearance for its Endoflip System with Flip Topography Module, providing a new way for clinicians to assess patient motility disorders...
06/07/18 - Industry
Product approval
Apollo Endosurgery has received Special 510(k) clearance from the FDA for the OverStitch Sx Endoscopic Suturing System. The OverStitch Sx System is a full-thickness flexible endoscopic suturing...
06/07/18 - Industry
Intragastric Balloons
Obalon Therapeutics has commented on the advisory issued by the FDA in June concerning the potential risks, including deaths, associated with liquid-filled intragastric balloons. The advisory was...
22/05/18 - Industry
Semaglutide and T2DM
Semaglutide is safe and effective for the treatment of type 2 diabetes, according to a review by researchers from the Aristotle University of Thessaloniki, Greece. The researchers found that...

Monthly archive